Eptinezumab (Vyepti) for migraine prevention.
Med Lett Drugs Ther
; 62(1599): 85-87, 2020 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-32555116
Key words
Aimovig; Ajovy; Atacand; Botox; Corgard; Cymbalta; Depakote; Effexor; Emgality; Epival; Inderal; Lopressor; SNRIs; Tenormin; Topamax; Vyepti; Ziac; adverse effects; amitriptyline; atenolol; beta blockers; bisoprolol; candesartan; dosage; duloxetine; efficacy; eptinezumab; erenumab; fremanezumab; galcanezumab; lactation; metoprolol; migraine; nadolol; onabotulinumtoxinA; pregnancy; propranolol; safety; timolol; topiramate; tricyclic antidepressants; venlafaxine
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Calcitonin Gene-Related Peptide Receptor Antagonists
/
Migraine Disorders
Limits:
Humans
Language:
En
Journal:
Med Lett Drugs Ther
Year:
2020
Document type:
Article
Country of publication:
Estados Unidos